Mary Lin
Visit Investigator ProfileInvestigation Details
Detailed Analysis
Mary Lin''s approach involves thoroughly scrutinizing scientific and clinical data to ensure regulatory compliance and safety in pharmaceutical manufacturing. She prioritizes evidence-based practices and comprehensive data analysis.
Mary Lin is a detail-oriented FDA auditor with a focus on the scientific and clinical aspects of pharmaceutical manufacturing and testing. She is particularly interested in the correlation between product properties and clinical biomarker levels, as well as the evaluation of immunomodulatory properties. She also prioritizes thorough data collection and analysis to support regulatory approval.
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies